218 related articles for article (PubMed ID: 30903681)
1. Overexpression of CMTM7 inhibits cell growth and migration in liver cancer.
Huang ZM; Li PL; Yang P; Hou XD; Yang YL; Xu X; Xu F
Kaohsiung J Med Sci; 2019 Jun; 35(6):332-340. PubMed ID: 30903681
[TBL] [Abstract][Full Text] [Related]
2. A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth.
Li H; Li J; Su Y; Fan Y; Guo X; Li L; Su X; Rong R; Ying J; Mo X; Liu K; Zhang Z; Yang F; Jiang G; Wang J; Zhang Y; Ma D; Tao Q; Han W
Oncogene; 2014 Jun; 33(24):3109-18. PubMed ID: 23893243
[TBL] [Abstract][Full Text] [Related]
3. SOX10-dependent CMTM7 expression inhibits cell proliferation and tumor growth in gastric carcinoma.
Jin Y; Qin X; Jia G
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):91-99. PubMed ID: 30392914
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7/EGFR/AKT axis.
Lu C; Zhao Y; Wang J; Shi W; Dong F; Xin Y; Zhao X; Liu C
Mol Med; 2021 Jul; 27(1):78. PubMed ID: 34294040
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of tripartite motif containing 26 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.
Tao JL; Luo M; Sun H; Zhao HM; Sun QS; Huang ZM
Kaohsiung J Med Sci; 2020 Jun; 36(6):417-422. PubMed ID: 32052576
[TBL] [Abstract][Full Text] [Related]
6. CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation.
Liu B; Su Y; Li T; Yuan W; Mo X; Li H; He Q; Ma D; Han W
Oncotarget; 2015 Dec; 6(38):41092-107. PubMed ID: 26528697
[TBL] [Abstract][Full Text] [Related]
7. CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells.
Li W; Zhang S
Oncol Res; 2017 Jan; 25(2):285-293. PubMed ID: 27629543
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
9. ZC3H15 Correlates with a Poor Prognosis and Tumor Progression in Melanoma.
Li Q; Hou J; Guo C; Zhang Y; Liu L; Hu H; Shi S; Ji Y; Guo L; Shi Y; Liu Y; Cui H
Biomed Res Int; 2021; 2021():8305299. PubMed ID: 34988227
[TBL] [Abstract][Full Text] [Related]
10. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
11. ClC-3 Chloride Channel Proteins Regulate the Cell Cycle by Up-regulating cyclin D1-CDK4/6 through Suppressing p21/p27 Expression in Nasopharyngeal Carcinoma Cells.
Ye D; Luo H; Lai Z; Zou L; Zhu L; Mao J; Jacob T; Ye W; Wang L; Chen L
Sci Rep; 2016 Jul; 6():30276. PubMed ID: 27451945
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA‑33a promotes cyclin‑dependent kinase 6, cyclin D1 and PIM1 expression and gastric cancer cell proliferation.
Wang Y; Zhou X; Shan B; Han J; Wang F; Fan X; Lv Y; Chang L; Liu W
Mol Med Rep; 2015 Nov; 12(5):6491-500. PubMed ID: 26352175
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-related receptor γ is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27.
Kim JH; Choi YK; Byun JK; Kim MK; Kang YN; Kim SH; Lee S; Jang BK; Park KG
Exp Mol Med; 2016 Mar; 48(3):e213. PubMed ID: 26940882
[TBL] [Abstract][Full Text] [Related]
14. CMTM7 inhibits breast cancer progression by regulating Wnt/β-catenin signaling.
Chen ZH; Tian Y; Zhou GL; Yue HR; Zhou XJ; Ma HY; Ge J; Wang X; Cao XC; Yu Y
Breast Cancer Res; 2023 Feb; 25(1):22. PubMed ID: 36829181
[TBL] [Abstract][Full Text] [Related]
15.
Li D; Huang S; Luo C; Xu Y; Fu S; Liu K; Wu J
Curr Oncol; 2023 Feb; 30(3):2653-2672. PubMed ID: 36975415
[TBL] [Abstract][Full Text] [Related]
16. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
Wang Z; Wei W; Sun CK; Chua MS; So S
Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
[TBL] [Abstract][Full Text] [Related]
17. Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM1 and CMTM3 as priority targets.
Delic S; Thuy A; Schulze M; Proescholdt MA; Dietrich P; Bosserhoff AK; Riemenschneider MJ
Genes Chromosomes Cancer; 2015 Jul; 54(7):433-43. PubMed ID: 25931111
[TBL] [Abstract][Full Text] [Related]
18. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
Takeuchi S; Kasamatsu A; Yamatoji M; Nakashima D; Endo-Sakamoto Y; Koide N; Takahara T; Shimizu T; Iyoda M; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Apr; 486(2):385-390. PubMed ID: 28315328
[TBL] [Abstract][Full Text] [Related]
19. MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability.
Wan C; Hou S; Ni R; Lv L; Ding Z; Huang X; Hang Q; He S; Wang Y; Cheng C; Gu XX; Xu G; Shen A
Oncogene; 2015 Jan; 34(2):237-45. PubMed ID: 24336329
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
Geng D; Zhao W; Feng Y; Liu J
Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]